Peripheral Arterial Disease: Identification and Implications

Archives of Internal Medicine

Volumn 163, Issue 19, 2003, Pages 2306-2314

  Mohler III, Emile R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; PENTOXIFYLLINE;

ALGORITHM; ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG ACTIVITY; FUNCTION TEST; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EXERCISE TEST; EXERCISE THERAPY; HUMANS; PERIPHERAL VASCULAR DISEASES; PHYSICAL EXAMINATION; PLATELET AGGREGATION INHIBITORS;

EID: 0142243263     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.19.2306     Document Type: Article

References (66)

1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR. Large vessel and isolated small vessel disease. In: Fowkes FGR, ed. Epidemiology of Peripheral Vascular Disease. New York, NY: Springer-Verlag; 1991:85-96.
2. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645-658.
3. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599-1606.
4. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026-3049.
5. Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest. 2001;119(suppl 1):283S-299S.
6. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand. 1982;211:249-256.
7. Skau T, Jonsson B. Prevalence of symptomatic leg ischaemia in a Swedish community - an epidemiological study. Eur J Vasc Surg. 1993;7:432-437.
8. Jelnes R, Gaardsting O, Hougaard Jensen K, Bækgaard N, Tønnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. BMJ. 1986;293:1137-1140.
9. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002;112:49-57.
10. Leng GC, Lee AJ, Fowkes FGR, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172-1181.
11. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 1999;12:123-137.
12. Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg. 2001;33:251-258.
13. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med. 1998;3:241-245.
14. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg. 1999;12:118-122.
15. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199:223-233.
16. Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47:1255-1256.
17. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1:333-339.
18. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2002.
19. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med. 1996;1:60-64.
20. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
21. Criqui MH, Langer RD, Fronek A, Feigelson HS. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs. 1991;42(suppl 5): 16-21.
22. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
23. Ouriel K. Detection of peripheral arterial disease in primary care. JAMA. 2001;286:1380-1381.
24. McLafferty RB, Dunnington GL, Mattos MA, et al. Factors affecting the diagnosis of peripheral vascular disease before vascular surgery referral. J Vasc Surg. 2000;31:870-879.
25. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31 (suppl 1, pt 2):S1-S296.
26. Olin JW. Clinical evaluation and office-based detection of peripheral arterial disease. Available at: http://www.svmb.org/medpro/cme/p1/cme-part1.html. Accessed November 2, 2000.
27. Halperin JL, Creager MA. Arterial obstructive diseases of the extremities. In: Loscalzo J, Creager M, Dzau V, eds. Vascular Medicine: A Textbook of Vascular Biology and Diseases. 2nd ed. New York, NY: Little Brown & Co Inc; 1996:825-852.
28. Jaff MR. Severe peripheral arterial disease and critical limb ischemia: incidence, pathophysiology, presentation, methods of diagnosis. Available at: http://www .svmb.org/medpro/cme/p3/cme_part3.html. Accessed January 7, 2002.
29. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18:185-192.
30. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71:516-522.
31. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:1440-1443.
32. Barnhorst DA, Barner HB. Prevalence of congenitally absent pedal pulses. N Engl J Med. 1968;278:264-265.
33. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608-1621.
34. McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med. 1999;133:33-40.
35. Hiatt WR, Jones DN. The role of hemodynamics and duplex ultrasound in the diagnosis of peripheral arterial disease. Curr Opin Cardiol. 1992;7:805-810.
36. Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86:615-618.
37. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91:686-693.
38. Müller-Bühl U, Wiesemann A, Oser B, Kirchberger I, Strecker E-P. Correlation of hemodynamic and functional variables with the angiographic extent of peripheral arterial occlusive disease. Vasc Med. 1999;4:247-251.
39. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969;56:676-679.
40. Baxter GM, Polak JF. Lower limb colour flow imaging: a comparison with ankle: brachial measurements and angiography. Clin Radiol. 1993;47:91-95.
41. Treiman GS, Oderich GSC, Ashrafi BA, Schneider PA. Management of ischemic heel ulceration and gangrene: an evaluation of factors associated with successful healing. J Vasc Surg. 2000;31:1110-1118.
42. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR, Langer RD. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med. 1999;4:15-21.
43. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the Women's Health and Aging Study. Circulation. 2000;101:1007-1012.
44. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures. J Am Geriatr Soc. 1994;42:923-929.
45. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-545.
46. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
47. Dormandy JA. Ankle:arm blood pressure index as a predictor of atherothrombotic events: evidence from CAPRIE [abstract]. Cerebrovasc Dis. 1999;9(suppl 1):14. Abstract 21.
48. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-128.
49. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc. 1997;45:1472-1478.
50. Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology. 1995;46:211-219.
51. Vogt MT, McKenna M, Anderson SJ, Wolfson SK, Kuller LH. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc. 1993;41:523-530.
52. Ogren M, Hedblad B, Isacsson S-O, Janzon L, Jungquist G, Lindell S-E. Ten year cerebrovascular morbidity and mortality in 68 year old men with asymptomatic carotid stenosis. BMJ. 1995;310:1294-1298.
53. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke. 2001;32:1721-1724.
54. Abbott RD, Rodriguez BL, Petrovitch H, et al. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol. 2001;54:973-978.
55. McPhail IR, Spittell PC, Weston SA, Bailey KR. Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol. 2001;37:1381-1385.
56. Amirhamzeh MMR, Chant HJ, Rees JL, Hands LJ, Powell RJ, Campbell WB. A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc Endovasc Surg. 1997;13:301-305.
57. Kuller LH. Is ankle-brachial blood pressure measurement of clinical utility for asymptomatic elderly? J Clin Epidemiol. 2001;54:971-972.
58. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
59. Department of Health and Human Services. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. 63 Federal Register 56802-56819 (1998) (codified at 21 CFR § 343).
60. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KAA. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
61. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
62. American Medical Association. CPT (Current Procedural Terminology) 2001. Chicago, III: American Medical Association; 2001.
63. Jaff M. Pharmacotherapy. In: Creager M, ed. Management of Peripheral Arterial Disease: Medical, Surgical and Interventional Aspects. London, England: Re-MEDICA Publishing Ltd; 2000:57-67.
64. Girolami B, Bernardi E, Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999;159:337-345.
65. Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. 1982;104:66-72.
66. Reilly MP, Mohler ER III. Cilostazol: treatment of intermittent claudication. Ann Pharmacother. 2001;35:48-56.